How do leukotriene receptor antagonists contribute to allergy management and asthma control?

How do leukotriene receptor antagonists contribute to allergy management and asthma control?

• A. Block leukotriene receptors, reducing inflammation and bronchoconstriction; useful for allergic rhinitis and mild-to-moderate persistent asthma; may have rare neuropsychiatric side effects.
• B. Block histamine receptors.
• C. Induce bronchodilation via beta-agonist effect.
• D. Inhibit prostaglandin synthesis.

Answer: (A)

Leukotriene receptor antagonists work by blocking the CysLT1 receptor for leukotrienes, key inflammatory mediators released in allergic responses. By blocking this receptor, they reduce leukotriene-driven inflammation, mucus production, edema, and bronchoconstriction. That makes them helpful for both allergic rhinitis and asthma that is mild to moderate in severity, often used as add-on therapy when inhaled corticosteroids don’t fully control symptoms or when an oral option is preferred. They can also help with exercise-induced bronchoconstriction in some patients. A note on safety: these drugs are generally well tolerated but can rarely cause neuropsychiatric effects such as mood changes or agitation, so watch for new or unusual symptoms in susceptible individuals. This mechanism differs from other options: they don’t block histamine receptors (antihistamines do that), they don’t create bronchodilation through beta-adrenergic effects (that’s what beta-agonists do), and they don’t inhibit prostaglandin synthesis (that’s what NSAIDs/COX inhibitors do).

Leukotriene receptor antagonists work by blocking the CysLT1 receptor for leukotrienes, key inflammatory mediators released in allergic responses. By blocking this receptor, they reduce leukotriene-driven inflammation, mucus production, edema, and bronchoconstriction. That makes them helpful for both allergic rhinitis and asthma that is mild to moderate in severity, often used as add-on therapy when inhaled corticosteroids don’t fully control symptoms or when an oral option is preferred. They can also help with exercise-induced bronchoconstriction in some patients.

A note on safety: these drugs are generally well tolerated but can rarely cause neuropsychiatric effects such as mood changes or agitation, so watch for new or unusual symptoms in susceptible individuals.

This mechanism differs from other options: they don’t block histamine receptors (antihistamines do that), they don’t create bronchodilation through beta-adrenergic effects (that’s what beta-agonists do), and they don’t inhibit prostaglandin synthesis (that’s what NSAIDs/COX inhibitors do).